Revero

Revero is an AI-driven digital health startup based in San Francisco, California, founded in 2019. The company focuses on reversing chronic metabolic and autoimmune conditions through a root-cause approach. Its personalized treatment platform combines nutrition therapy, biomarker tracking, and remote medical care. Revero has experienced significant growth, with nearly 3,000 paying subscribers and annual revenue exceeding $500,000. In 2023, it secured $5 million in seed funding to expand its offerings. Revero's core services include customized nutrition therapy, continuous biomarker monitoring, and ongoing clinical support from healthcare providers. The platform addresses various chronic conditions, such as type 2 diabetes, obesity, and autoimmune disorders like Crohn’s disease and rheumatoid arthritis. Revero serves individuals through a subscription model and also partners with self-insured employers and health plans to reduce healthcare costs. The company aims to expand its services across the U.S. and globally, with a vision to help millions of patients reverse chronic diseases.